Neos Therapeutics Inc
NEOS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$57.22M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $57.22 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.34 |
| Beta | - |
| Outstanding Shares | 49,755,094 |
Return
| Return on Equity | 106.35% |
|---|---|
| Return on Assets | -33.84% |
| Return on Invested Capital | 519.75% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 1.15 |
| Price to Book Ratio | -1.15 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | -1.97 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Neos Therapeutics Inc
CEO: Gerald McLaughlin
